Story perspectives

Sanders Presses FDA Nominee Over Trump Drug-Price Claims

By Drooid · Sep 25, 2026, 12:27 AM UTC · How we work

Left

Trump price claim busted

On September 24 2026, Senator Bernie Sanders questioned FDA nominee Dr. Heidi Overton during a Senate hearing.
The hearing underscored that prescription-drug prices rose under President Donald Trump, contradicting his claim of the lowest global prices.
Sanders’ office cited price hikes on 688 drugs, median increase 5.5 % in Trump’s second term.
A 2024 RAND study found Americans pay three times more for prescriptions than other nations.

Right

Overton Evades Answer

On September 24, 2026, Senator Bernie Sanders questioned FDA nominee Dr. Heidi Overton about President Donald Trump's claim U.S. has lowest prescription drug prices.
Senator Sanders pressed Overton to call healthcare a human right, but she avoided a direct yes-or-no answer.
She was nominated to replace Dr. Marty Makary, who quit FDA vape policy dispute.
Sanders, living near the Canadian border, highlighted doctors are more accessible there than in U.S.

Blindspot

Sanders' office reported that 688 prescription drugs saw price hikes, with a median increase of 5.5% during the first year of President Donald Trump's second term.
Within this story's sources, this angle appears mainly in Left-leaning coverage and receives less attention in Right-leaning coverage.

1 of 3

Trump price claim busted

On September 24 2026, Senator Bernie Sanders questioned FDA nominee Dr. Heidi Overton during a Senate hearing.
The hearing underscored that prescription-drug prices rose under President Donald Trump, contradicting his claim of the lowest global prices.
Sanders’ office cited price hikes on 688 drugs, median increase 5.5 % in Trump’s second term.
A 2024 RAND study found Americans pay three times more for prescriptions than other nations.

1 / 3